Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of GLP-1 receptor agonists and dietary behavior in type 2 diabetes
jRCT1041250212Completed
- Start
- Sep 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by none. Primary endpoint: Change in HbA1c at 52 weeks. Started Sep 2021; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1041250212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041250212.